Are MENS insiders buying or selling?

In the last 90 days, Jyong (MENS) had 0 insider transactions. Track every executive trade, dollar amount, and date.

Which hedge funds own MENS?

See every hedge fund and asset manager holding Jyong (MENS).

How much of MENS trades in dark pools?

Track Jyong (MENS) dark pool activity and off-exchange block trades.

Jyong (MENS) — 51.4% Short — Squeeze Watch

$2.05

-0.13 (-5.86%)

Weekly Expected Move ±8.5%

$2 $2 $2 $2 $2

NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 34 · $165.7M mcap · 28M float · 0.624% daily turnover · Short 52% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Smart Money Score

Watch 0

Insider—

Congress—

ETF Holdings—

Key Statistics

Market Cap$165.7M

52W Range1.43-67

Volume58,434

Avg Volume175,006

Beta2.62

Dividend—

Analyst Ratings

No analyst coverage

Company Info

CEOFu-Feng Kuo

Employees31

SectorHealthcare

IndustryBiotechnology

IPO Date2025-06-17

Websitejyongbio.com/

23Fâ3, No.â¯95, Section 1, Xintai 5th Road
New Taipei City 221
TW

886 2 2732 5205

About Jyong Biotech Ltd. Ordinary Shares

Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiariesâHealth Ever Bio-Tech, Genvace, and othersâworking on drug candidates like MCSâ2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages

Latest News

Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025

Benzinga-Biotech · 5d ago